• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湄公血吸虫病快速诊断的侧向流动免疫分析的研制与准确性评价。

Development and Accuracy Evaluation of Lateral Flow Immunoassay for Rapid Diagnosis of Schistosomiasis Mekongi in Humans.

机构信息

Department of Parasitology and Excellence in Medical Innovation, and Technology Research Group, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Mekong Health Science Research Institute, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Vector Borne Zoonotic Dis. 2022 Jan;22(1):48-54. doi: 10.1089/vbz.2021.0053. Epub 2022 Jan 3.

DOI:10.1089/vbz.2021.0053
PMID:34981973
Abstract

infection is endemic in countries along the Mekong River and certain of its tributaries in the lower Mekong basin, especially in Lao People's Democratic Republic and Cambodia. Diagnosis of schistosomiasis is crucial before treatment and epidemiological surveys before and/or after an intervention, such as a mass drug administration. A newly developed immunochromatographic test (ICT) for the diagnosis of schistosomiasis mekongi, based on antiparasite antibody detection in human sera, was evaluated. The schistosomiasis mekongiICT (ICT) strip was developed using somatic antigen from adult . In total, 209 serum samples were examined, including 14 from parasitologically proven schistosomiasis mekongi patients, 30 from schistosomiasis japonica patients, other parasitosis ( = 135), and healthy volunteers ( = 30) from areas not endemic for . Eleven schistosomiasis mekongi samples were positive according to the ICT, whereas all healthy control samples were negative. Crossreactions with paragonimiasis heterotremus, sparganosis, trichinellosis, and taeniasis saginata samples were observed at 2.4% (4/165). The diagnostic sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 78.6% (95% confidence interval [CI] 49.2-95.3), 97.6% (95% CI 93.9-99.3), 73.3% (95% CI 44.9-92.2), 98.2% (95% CI 94.7-99.6), and 96.1% (95% CI 92.1-98.4), respectively. The ICT kit might be useful to assess the prevalence of disease before establishing transmission control and mass deworming campaigns in countries in the Mekong River subregion.

摘要

在湄公河流域及其下游的一些支流国家,如老挝人民民主共和国和柬埔寨,曼氏血吸虫病呈地方性流行。在进行治疗和在干预(如大规模药物治疗)前后进行流行病学调查之前,对血吸虫病进行诊断至关重要。本研究评估了一种新开发的曼氏血吸虫病免疫层析检测法(ICT),该方法基于人体血清中寄生虫抗体的检测。曼氏血吸虫病 ICT 条带是使用成虫的体抗原开发的。共检测了 209 份血清样本,包括 14 份寄生虫学证实的曼氏血吸虫病患者、30 份日本血吸虫病患者、其他寄生虫病(=135 例)和非曼氏血吸虫病流行地区的健康志愿者(=30 例)。根据 ICT,有 11 份曼氏血吸虫病样本呈阳性,而所有健康对照样本均为阴性。与并殖吸虫病、裂头蚴病、旋毛虫病和带绦虫病样本的交叉反应率为 2.4%(4/165)。诊断的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为 78.6%(95%置信区间 49.2-95.3)、97.6%(95%置信区间 93.9-99.3)、73.3%(95%置信区间 44.9-92.2)、98.2%(95%置信区间 94.7-99.6)和 96.1%(95%置信区间 92.1-98.4)。该 ICT 试剂盒可能有助于评估湄公河流域国家在开展疾病传播控制和大规模驱虫运动之前的疾病流行情况。

相似文献

1
Development and Accuracy Evaluation of Lateral Flow Immunoassay for Rapid Diagnosis of Schistosomiasis Mekongi in Humans.湄公血吸虫病快速诊断的侧向流动免疫分析的研制与准确性评价。
Vector Borne Zoonotic Dis. 2022 Jan;22(1):48-54. doi: 10.1089/vbz.2021.0053. Epub 2022 Jan 3.
2
Comparison of novel and standard diagnostic tools for the detection of Schistosoma mekongi infection in Lao People's Democratic Republic and Cambodia.老挝人民民主共和国和柬埔寨用于检测湄公血吸虫感染的新型诊断工具与标准诊断工具的比较
Infect Dis Poverty. 2017 Aug 10;6(1):127. doi: 10.1186/s40249-017-0335-x.
3
Cross-reaction of POC-CCA urine test for detection of Schistosoma mekongi in Lao PDR: a cross-sectional study.老挝人民民主共和国 POCT-CCA 尿液检测法检测湄公血吸虫的交叉反应:一项横断面研究。
Infect Dis Poverty. 2020 Aug 12;9(1):114. doi: 10.1186/s40249-020-00733-z.
4
Schistosoma mekongi in Cambodia and Lao People's Democratic Republic.柬埔寨和老挝人民民主共和国的湄公血吸虫。
Adv Parasitol. 2010;72:179-203. doi: 10.1016/S0065-308X(10)72007-8.
5
Schistosomiasis mekongi: from discovery to control.湄公血吸虫病:从发现到控制
Parasitol Int. 2004 Jun;53(2):135-42. doi: 10.1016/j.parint.2004.01.004.
6
Integrated Eco-Health approach significantly reduces helminth infections in endemic Khong islands with emphasis on Schistosoma mekongi.综合生态健康方法显著降低了流行地区孔岛的寄生虫感染,重点是湄公血吸虫。
Infect Dis Poverty. 2024 Aug 2;13(1):57. doi: 10.1186/s40249-024-01226-z.
7
Transcriptomic analysis of male and female Schistosoma mekongi adult worms.转录组分析雄性和雌性湄公血吸虫成虫。
Parasit Vectors. 2018 Sep 10;11(1):504. doi: 10.1186/s13071-018-3086-z.
8
Patients with severe schistosomiasis mekongi morbidity demonstrating ongoing transmission in Southern Lao People's Democratic Republic.在老挝人民民主共和国南部,严重湄公血吸虫病发病率高的患者表明仍有传播。
Acta Trop. 2020 Apr;204:105323. doi: 10.1016/j.actatropica.2019.105323. Epub 2019 Dec 28.
9
Schistosoma mekongi cathepsin B and its use in the development of an immunodiagnosis.湄公血吸虫组织蛋白酶B及其在免疫诊断开发中的应用
Acta Trop. 2016 Mar;155:11-9. doi: 10.1016/j.actatropica.2015.11.017. Epub 2015 Dec 2.
10
Morbidity associated with Schistosoma mekongi and concurrent helminth infection in Lao People's Democratic Republic.老挝人民民主共和国湄公血吸虫病及并发寄生虫感染的发病情况。
Acta Trop. 2020 Apr;204:105324. doi: 10.1016/j.actatropica.2019.105324. Epub 2019 Dec 28.

引用本文的文献

1
A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis.人类血吸虫病诊断、治疗及疫苗研发的最新进展
Trop Med Infect Dis. 2024 Oct 15;9(10):243. doi: 10.3390/tropicalmed9100243.
2
Exploring urinary proteomics and peptidomics biomarkers for the diagnosis of mekong schistosomiasis.探索用于湄公血吸虫病诊断的尿液蛋白质组学和肽组学生物标志物。
Heliyon. 2024 Jul 30;10(15):e35439. doi: 10.1016/j.heliyon.2024.e35439. eCollection 2024 Aug 15.
3
Making the Most of Lateral Flow Immunochromatographic Tests: An Efficient Protocol to Recover DNA.
充分利用侧向流动免疫层析试验:一种高效的DNA回收方案。
Methods Protoc. 2024 Jan 15;7(1):8. doi: 10.3390/mps7010008.
4
Cloning, Expression and Evaluation of Thioredoxin Peroxidase-1 Antigen for the Serological Diagnosis of Human Infection.用于人类感染血清学诊断的硫氧还蛋白过氧化物酶-1抗原的克隆、表达及评估
Diagnostics (Basel). 2022 Dec 7;12(12):3077. doi: 10.3390/diagnostics12123077.